TrialCancer chemotherapy and pharmacology2024

Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).

Vassilios Aslanis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.